Literature DB >> 17290104

Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk.

Jon Infante1, Javier Llorca, Ignacio Mateo, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Pascual Sánchez-Juan, Carlos Fernández-Viadero, Nicolás Peña, José Berciano, Onofre Combarros.   

Abstract

Excessive release of proinflammatory cytokines by activated microglia surrounding senile plaques might contribute to the neurodegeneration associated with Alzheimer's disease (AD). Poly(ADP-ribose) polymerase 1 (PARP-1) is a nuclear protein recently implicated in the initial inflammatory response by modulating expression of inflammation-related genes, like interleukin 1 (IL-1). As PARP-1 overactivity has been shown in the AD brain, we tested the hypothesis that the PARP-1 -410 and -1672 polymorphisms would predispose people to AD due to overexpression of the PARP-1 gene, independently or in concert with the proinflammatory IL-1A -889 polymorphism. So, we performed a case-control study in 263 Spanish AD patients and 293 healthy controls. PARP-1 -410 and PARP-1 -1672 haplotypes were associated with an increased risk for AD (global haplotype association p value=0.019), and, in addition, PARP-1 haplotypes increased the risk of AD by interaction with the IL-1A -889 allele 2. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17290104     DOI: 10.1159/000099471

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  16 in total

1.  Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

Authors:  Hsin-Ping Liu; Wei-Yong Lin; Bor-Tsang Wu; Shu-Hsiang Liu; Wen-Fu Wang; Chon-Haw Tsai; Chun-Cheng Lee; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 3.  Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies.

Authors:  Xue Qin; Qiliu Peng; Zhiyu Zeng; Zhiping Chen; Liwen Lin; Yan Deng; Xiamei Huang; Juanjuan Xu; Huiling Wu; Shan Huang; Shan Li; Jinmin Zhao
Journal:  J Neurol       Date:  2012-01-11       Impact factor: 4.849

4.  Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Lu Guo; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing Xiang; Jing-Cheng Li
Journal:  J Neural Transm (Vienna)       Date:  2012-07-28       Impact factor: 3.575

Review 5.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

6.  Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease.

Authors:  Ji-Liang Hu; Gang Li; De-Xiang Zhou; Yu-Xi Zou; Zhi-Shan Zhu; Ru-Xiang Xu; Xiao-Dan Jiang; Yan-Jun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-08-15       Impact factor: 5.046

7.  Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.

Authors:  K Nho; J J Corneveaux; S Kim; H Lin; S L Risacher; L Shen; S Swaminathan; V K Ramanan; Y Liu; T Foroud; M H Inlow; A L Siniard; R A Reiman; P S Aisen; R C Petersen; R C Green; C R Jack; M W Weiner; C T Baldwin; K Lunetta; L A Farrer; S J Furney; S Lovestone; A Simmons; P Mecocci; B Vellas; M Tsolaki; I Kloszewska; H Soininen; B C McDonald; M R Farlow; B Ghetti; M J Huentelman; A J Saykin
Journal:  Mol Psychiatry       Date:  2013-04-23       Impact factor: 15.992

Review 8.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

9.  The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients.

Authors:  Ilhan Onaran; Gülçin Tezcan; Levent Ozgönenel; Esra Cetin; Alper Tunga Ozdemir; Gönül Kanigür-Sultuybek
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

10.  Molecular cloning, overexpression and characterization of human interleukin 1alpha.

Authors:  Dakshinamurthy Rajalingam; Doreen Kacer; Igor Prudovsky; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  Biochem Biophys Res Commun       Date:  2007-06-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.